Business Segments · CapEx
Health & Biosciences — CapEx
International Flavors & Fragrances Health & Biosciences — CapEx increased by 19.6% to $55.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 37.5%, from $40.00M to $55.00M. Over 4 years (FY 2021 to FY 2025), Health & Biosciences — CapEx shows relatively stable performance with a 1.1% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2019
Last reportedQ1 2026May 5, 2026
Rolls up toProperty, plant, and equipment additions
How to read this metric
High levels of capital expenditure indicate growth investment, while low levels may suggest a focus on cash preservation or asset maturity.
Detailed definition
Funds used by the Health & Biosciences segment to acquire, upgrade, and maintain physical assets such as property, plant...
Peer comparison
Standard 'CapEx' metric reported by capital-intensive manufacturing companies.
Metric ID:
iff_segment_health_biosciences_capital_expendituresHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $34.75M | $34.75M | $34.75M | $40.00M | $40.00M | $40.00M | $40.00M | $21.25M | $21.25M | $21.25M | $21.25M | $16.00M | $19.00M | $17.00M | $21.00M | $40.00M | $22.00M | $37.00M | $46.00M | $55.00M |
| QoQ Change | — | +0.0% | +0.0% | +15.1% | +0.0% | +0.0% | +0.0% | -46.9% | +0.0% | +0.0% | +0.0% | -24.7% | +18.8% | -10.5% | +23.5% | +90.5% | -45.0% | +68.2% | +24.3% | +19.6% |
| YoY Change | — | — | — | — | +15.1% | +15.1% | +15.1% | -46.9% | -46.9% | -46.9% | -46.9% | -24.7% | -10.6% | -20.0% | -1.2% | +150.0% | +15.8% | +117.6% | +119.0% | +37.5% |
Range$16.00M – $55.00M
CAGR+10.1%
Avg YoY Growth+15.1%
Median YoY Growth+7.0%
Current Streak3 quarters growth
Similar Metrics at Other Companies
Frequently Asked Questions
- What is International Flavors & Fragrances's health & biosciences — capex?
- International Flavors & Fragrances (IFF) reported health & biosciences — capex of $55.00M in Q1 2026.
- How has International Flavors & Fragrances's health & biosciences — capex changed year-over-year?
- International Flavors & Fragrances's health & biosciences — capex increased by 37.5% year-over-year, from $40.00M to $55.00M.
- What is the long-term trend for International Flavors & Fragrances's health & biosciences — capex?
- Over 4 years (2021 to 2025), International Flavors & Fragrances's health & biosciences — capex has grown at a 1.1% compound annual growth rate (CAGR), from $139.00M to $145.00M.
- What does health & biosciences — capex mean?
- Investment in physical assets and infrastructure for the segment.